Julie Jordan, Chief Officer of Neurogene NGNE, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $18.1K. The latest trade was on 03/26.

Julie Jordan

Chief Medical Officer

Company: Neurogene NGNE
First filing: 23/08/07

Trades: 18 trades
Buys / sales: 0 / 5
12-month net buying: −$18.1K
Last trade: 03/26

Trading activity

Transactions

	Trade type
NeurogeneNGNE	Open-market sale10b5-1 plan	03/26	03/30	828 sh	$21.89	$18,124.92	−6.2%
QTTB	Open-market sale10b5-1 plan	23/08/03	23/08/07	1,853 sh3 trades	$1.39avg.	$2,575.67	−19.8%
Q32 BioQTTB	Open-market sale10b5-1 plan	23/08/02	23/08/04	99 sh	$1.31	$129.69	−3.5%